Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2016

Open Access 01-12-2016 | Study protocol

Effect of Cosmos caudatus (Ulam raja) supplementation in patients with type 2 diabetes: Study protocol for a randomized controlled trial

Authors: Shi-Hui Cheng, Amin Ismail, Joseph Anthony, Ooi Chuan Ng, Azizah Abdul Hamid, Barakatun-Nisak Mohd Yusof

Published in: BMC Complementary Medicine and Therapies | Issue 1/2016

Login to get access

Abstract

Background

Type 2 diabetes mellitus is a major health threat worldwide. Cosmos caudatus is one of the medicinal plants used to treat type 2 diabetes. Therefore, this study aims to determine the effectiveness and safety of C. caudatus in patients with type 2 diabetes. Metabolomic approach will be carried out to compare the metabolite profiles between C. Caudatus treated diabetic patients and diabetic controls.

Methods and design

This is a single-center, randomized, controlled, two-arm parallel design clinical trial that will be carried out in a tertiary hospital in Malaysia. In this study, 100 patients diagnosed with type 2 diabetes will be enrolled. Diabetic patients who meet the eligibility criteria will be randomly allocated to two groups, which are diabetic C. caudatus treated(U) group and diabetic control (C) group. Primary and secondary outcomes will be measured at baseline, 4, 8, and 12 weeks. The serum and urine metabolome of both groups will be examined using proton NMR spectroscopy.

Discussion

The study will be the first randomized controlled trial to assess whether C. caudatus can confer beneficial effect in patients with type 2 diabetes. The results of this trial will provide clinical evidence on the effectiveness and safety of C. caudatus in patients with type 2 diabetes.

Trial registration

ClinicalTrials.gov identifier: NCT02322268
Literature
1.
go back to reference International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels: International Diabetes Federation; 2013. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels: International Diabetes Federation; 2013.
2.
go back to reference Institute for Public Health. The fourth National Health & Morbidity Survey 2011 (NHMS IV). Kuala Lumpur: National Institutes of Health Malaysia: Ministry of Health; 2011. Institute for Public Health. The fourth National Health & Morbidity Survey 2011 (NHMS IV). Kuala Lumpur: National Institutes of Health Malaysia: Ministry of Health; 2011.
3.
go back to reference Mafauzy M, Hussein Z, Chan SP. The status of diabetes control in Malaysia: Results of DiabCare 2008. Med J Malaysia. 2011;66(3):175–81.PubMed Mafauzy M, Hussein Z, Chan SP. The status of diabetes control in Malaysia: Results of DiabCare 2008. Med J Malaysia. 2011;66(3):175–81.PubMed
4.
go back to reference Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77–82.CrossRef Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77–82.CrossRef
5.
go back to reference Nauck M, Frid A, Hermansen K, Shah NS, Tankova T, Mitha IH, et al. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)- 2 study. Diabetes Care. 2009;32(1):84–90.PubMedCentralCrossRefPubMed Nauck M, Frid A, Hermansen K, Shah NS, Tankova T, Mitha IH, et al. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)- 2 study. Diabetes Care. 2009;32(1):84–90.PubMedCentralCrossRefPubMed
6.
go back to reference Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–79.PubMedCentralCrossRefPubMed Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364–79.PubMedCentralCrossRefPubMed
7.
go back to reference Ball AJ, Flatt PR, McClenaghan NH. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide. Eur J Pharmacol. 2000;408(3):327–33.CrossRefPubMed Ball AJ, Flatt PR, McClenaghan NH. Desensitization of sulphonylurea- and nutrient-induced insulin secretion following prolonged treatment with glibenclamide. Eur J Pharmacol. 2000;408(3):327–33.CrossRefPubMed
8.
go back to reference Van Raalte DH, Diamant M. Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? Diabetes Res Clin Pract. 2011;93 Suppl 1:S37–46.CrossRefPubMed Van Raalte DH, Diamant M. Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy? Diabetes Res Clin Pract. 2011;93 Suppl 1:S37–46.CrossRefPubMed
9.
go back to reference Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9(4):301–14.PubMedCentralCrossRefPubMed Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9(4):301–14.PubMedCentralCrossRefPubMed
11.
go back to reference Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res. 2008;638(1–2):98–102.CrossRefPubMed Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res. 2008;638(1–2):98–102.CrossRefPubMed
12.
go back to reference Kuppusamy UR, Indran M, Rokiah P. Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients. Diabet Med. 2005;22(10):1343–6.CrossRefPubMed Kuppusamy UR, Indran M, Rokiah P. Glycaemic control in relation to xanthine oxidase and antioxidant indices in Malaysian Type 2 diabetes patients. Diabet Med. 2005;22(10):1343–6.CrossRefPubMed
13.
go back to reference Styskal J, Van Remmen H, Richardson A, Salmon AB. Oxidative stress and diabetes: What can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic Biol Med. 2012;52(1):46–58.PubMedCentralCrossRefPubMed Styskal J, Van Remmen H, Richardson A, Salmon AB. Oxidative stress and diabetes: What can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic Biol Med. 2012;52(1):46–58.PubMedCentralCrossRefPubMed
14.
go back to reference Surya S, Salam AD, Tomy DV, Carla B, Kumar RA, Sunil C. Diabetes mellitus and medicinal plants-a review. Asian Pac J Trop Dis. 2014;4(5):337–47.CrossRef Surya S, Salam AD, Tomy DV, Carla B, Kumar RA, Sunil C. Diabetes mellitus and medicinal plants-a review. Asian Pac J Trop Dis. 2014;4(5):337–47.CrossRef
15.
go back to reference Bailey CJ, Campbell IW, Chan JCN, Davidson JA, Howlett HCS, Ritz P. Metformin- the Gold Standard: A Scientific handbook. Chichester: Wiley; 2007. Bailey CJ, Campbell IW, Chan JCN, Davidson JA, Howlett HCS, Ritz P. Metformin- the Gold Standard: A Scientific handbook. Chichester: Wiley; 2007.
16.
go back to reference Cheng S-H, Barakatun-Nisak MY, Anthony J, Ismail A. Potential medicinal benefits of Cosmos caudatus (Ulam Raja): A scoping review. J Res Med Sci. 2015;20:1000–6.CrossRef Cheng S-H, Barakatun-Nisak MY, Anthony J, Ismail A. Potential medicinal benefits of Cosmos caudatus (Ulam Raja): A scoping review. J Res Med Sci. 2015;20:1000–6.CrossRef
17.
go back to reference Sekar M, Zulhilmi M, Hamdi AY, Nabila N, Zahida Z, Shafiq M. Ten commonly available medicinal plants in Malaysia used for the treatment of diabetes-a review. Asian J Pharm Clin Res. 2014;7(1):1–5. Sekar M, Zulhilmi M, Hamdi AY, Nabila N, Zahida Z, Shafiq M. Ten commonly available medicinal plants in Malaysia used for the treatment of diabetes-a review. Asian J Pharm Clin Res. 2014;7(1):1–5.
18.
go back to reference Abas F, Shaari K, Lajis NH, Israf DA, Kalsom YU. Antioxidative and radical scavenging properties of the constituents isolated from Cosmos caudatus Kunth. Nat Prod Res. 2003;9(4):245–8. Abas F, Shaari K, Lajis NH, Israf DA, Kalsom YU. Antioxidative and radical scavenging properties of the constituents isolated from Cosmos caudatus Kunth. Nat Prod Res. 2003;9(4):245–8.
19.
go back to reference Mustafa RA, Abdul HA, Mohamed S, Bakar FA. Total phenolic compounds, flavonoids, and radical scavenging activity of 21 selected tropical plants. J Food Sci. 2010;75(1):C28–35.CrossRefPubMed Mustafa RA, Abdul HA, Mohamed S, Bakar FA. Total phenolic compounds, flavonoids, and radical scavenging activity of 21 selected tropical plants. J Food Sci. 2010;75(1):C28–35.CrossRefPubMed
20.
go back to reference Shui GH, Leong LP, Wong SP. Rapid screening and characterization of antioxidants of Cosmos caudatus using liquid chromatography coupled with mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;827(1):127–38.CrossRefPubMed Shui GH, Leong LP, Wong SP. Rapid screening and characterization of antioxidants of Cosmos caudatus using liquid chromatography coupled with mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;827(1):127–38.CrossRefPubMed
21.
go back to reference Sukrasno, Fidriany I, Anggadiredja K, Handayani WA, Anam K. Influence of drying method on flavonoid content of Cosmos caudatus (kunth) leaves. Res J Med Plant. 2011;5(2):189–95.CrossRef Sukrasno, Fidriany I, Anggadiredja K, Handayani WA, Anam K. Influence of drying method on flavonoid content of Cosmos caudatus (kunth) leaves. Res J Med Plant. 2011;5(2):189–95.CrossRef
22.
go back to reference Leong LP, Shui G. An investigation of antioxidant capacity of fruits in Singapore markets. Food Chem. 2002;76(1):69–75.CrossRef Leong LP, Shui G. An investigation of antioxidant capacity of fruits in Singapore markets. Food Chem. 2002;76(1):69–75.CrossRef
23.
go back to reference Perumal V, Hamid AA, Ismail A, Saari K, Abas F. Effect of Cosmos caudatus Kunth leaves on the lipid profile of a hyperlipidemia-induced animal model. J Food Chem Nutr. 2014;2(1):43–51. Perumal V, Hamid AA, Ismail A, Saari K, Abas F. Effect of Cosmos caudatus Kunth leaves on the lipid profile of a hyperlipidemia-induced animal model. J Food Chem Nutr. 2014;2(1):43–51.
24.
go back to reference Amalia L, Anggadiredja K, Sukrasno, Fidrianny I, Inggraini R. Antihypertensive potency of wild Cosmos (Cosmos caudatus Kunth, Asteraceae) leaf extract. J Pharmacol Toxicol. 2012;7(8):359–68.CrossRef Amalia L, Anggadiredja K, Sukrasno, Fidrianny I, Inggraini R. Antihypertensive potency of wild Cosmos (Cosmos caudatus Kunth, Asteraceae) leaf extract. J Pharmacol Toxicol. 2012;7(8):359–68.CrossRef
25.
go back to reference Ajaykumar TV, Anandarajagopal K, Sunilson JAJ, Arshad A, Jainaf RAM, Venkateshan N. Anti-inflammatory activity of Cosmos Caudatus. Int J Univers Pharm Bio Sci. 2012;1(2):40–8. Ajaykumar TV, Anandarajagopal K, Sunilson JAJ, Arshad A, Jainaf RAM, Venkateshan N. Anti-inflammatory activity of Cosmos Caudatus. Int J Univers Pharm Bio Sci. 2012;1(2):40–8.
26.
28.
go back to reference Brennan L. Progress in Nuclear Magnetic Resonance Spectroscopy NMR-based metabolomics : From sample preparation to applications in nutrition research. Prog Nucl Magn Reson Spectrosc. 2014;83:42–9.CrossRefPubMed Brennan L. Progress in Nuclear Magnetic Resonance Spectroscopy NMR-based metabolomics : From sample preparation to applications in nutrition research. Prog Nucl Magn Reson Spectrosc. 2014;83:42–9.CrossRefPubMed
29.
go back to reference Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med. 2009;22(5):507–12.CrossRefPubMed Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med. 2009;22(5):507–12.CrossRefPubMed
30.
go back to reference WHO. Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: World Health Organization; 1997. WHO. Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva: World Health Organization; 1997.
32.
go back to reference Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.CrossRefPubMed Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.CrossRefPubMed
33.
go back to reference Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Ann Intern Med. 2010;152(11):726–32.CrossRefPubMed Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Ann Intern Med. 2010;152(11):726–32.CrossRefPubMed
34.
go back to reference Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 2006;27(1):1–93.CrossRefPubMed Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med. 2006;27(1):1–93.CrossRefPubMed
35.
go back to reference Smolinska A, Blanchet L, Buydens LMC, Wijmenga SS. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta. 2012;750:82–97.CrossRefPubMed Smolinska A, Blanchet L, Buydens LMC, Wijmenga SS. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta. 2012;750:82–97.CrossRefPubMed
36.
go back to reference Griffin JL, Atherton H, Shockcor J, Atzori L. Metabolomics as a tool for cardiac research. Nat Rev Cardiol. 2011;8(11):630–43.CrossRefPubMed Griffin JL, Atherton H, Shockcor J, Atzori L. Metabolomics as a tool for cardiac research. Nat Rev Cardiol. 2011;8(11):630–43.CrossRefPubMed
37.
go back to reference Duarte IF, Diaz SO, Gil AM. NMR metabolomics of human blood and urine in disease research. J Pharm Biomed Anal. 2014;93:17–26.CrossRefPubMed Duarte IF, Diaz SO, Gil AM. NMR metabolomics of human blood and urine in disease research. J Pharm Biomed Anal. 2014;93:17–26.CrossRefPubMed
39.
go back to reference Savorani F, Rasmussen MA, Mikkelsen MS, Engelsen SB. A primer to nutritional metabolomics by NMR spectroscopy and chemometrics. Food Res Int. 2013;54(1):1131–45.CrossRef Savorani F, Rasmussen MA, Mikkelsen MS, Engelsen SB. A primer to nutritional metabolomics by NMR spectroscopy and chemometrics. Food Res Int. 2013;54(1):1131–45.CrossRef
40.
go back to reference Roberts LD, Koulman A, Griffin JL. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol. 2014;2(1):65–75.CrossRefPubMed Roberts LD, Koulman A, Griffin JL. Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome. Lancet Diabetes Endocrinol. 2014;2(1):65–75.CrossRefPubMed
Metadata
Title
Effect of Cosmos caudatus (Ulam raja) supplementation in patients with type 2 diabetes: Study protocol for a randomized controlled trial
Authors
Shi-Hui Cheng
Amin Ismail
Joseph Anthony
Ooi Chuan Ng
Azizah Abdul Hamid
Barakatun-Nisak Mohd Yusof
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2016
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-016-1047-7

Other articles of this Issue 1/2016

BMC Complementary Medicine and Therapies 1/2016 Go to the issue